A new AI model accurately detected cardiac amyloidosis from echocardiograms with higher accuracy vs. other amyloidosis risk ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...

The AI model uses a single echocardiography videoclip to differentiate cardiac amyloidosis from other similar heart ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

GE HealthCare Technologies Inc. (NASDAQ: GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...

Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.

Researchers developed trehalose-functionalized peptide amphiphiles (TPAs) that self-assemble into supramolecular nanostructures and demonstrated these TPAs can inhibit amyloid beta aggregation. In ...

Learn how to navigate your diagnosis of hereditary transthyretin amyloidosis (hATTR) with polyneuropathy.

The efficient detection and monitoring of amyloid-β plaques (Aβ42) can greatly promote the diagnosis and therapy of Alzheimer’s disease (AD). Fluorescence imaging is a promising method for this, but ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's.